Free Trial

Immunovant (IMVT) Insider Trading & Ownership

Immunovant logo
$27.99 +0.77 (+2.83%)
As of 09:57 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Immunovant (NASDAQ:IMVT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$3.75M
Get IMVT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Immunovant stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMVT Insider Buying and Selling by Quarter

Immunovant Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/1/2026
Robert Graham Susman
Director
Sell2,502$27.17$67,979.34  
4/23/2026Sell2,754$29.62$81,573.48  
4/23/2026Sell25,760$29.62$763,011.20  
4/8/2026Sell10,132$24.83$251,577.56  
4/8/2026Sell8,722$24.83$216,567.26  
4/8/2026Sell5,165$24.83$128,246.95  
4/2/2026
Eric Venker
CEO
Sell14,229$24.10$342,918.90  
3/18/2026Sell2,877$24.97$71,838.69  
1/21/2026Sell1,977$26.03$51,461.31  
1/7/2026Sell1,203$26.53$31,915.59  
12/18/2025Sell10,813$26.91$290,977.83  
12/1/2025Sell22,249$23.25$517,289.25  
12/1/2025Sell15,000$23.24$348,600.00  
11/20/2025Sell12,626$23.62$298,226.12  
10/22/2025Sell2,520$19.03$47,955.60  
10/22/2025Sell2,595$19.03$49,382.85  
10/8/2025Sell1,585$16.30$25,835.50  
10/8/2025Sell1,272$16.30$20,733.60  
7/23/2025Sell2,805$18.15$50,910.75  
7/23/2025Sell2,385$18.15$43,287.75  
7/9/2025Sell1,519$17.24$26,187.56  
7/9/2025Sell1,160$17.24$19,998.40  
(Data available from 1/1/2013 forward)

IMVT Insider Trading Activity - Frequently Asked Questions

1.80% of Immunovant stock is owned by insiders. Learn more on IMVT's insider holdings.

The following insider purchased IMVT shares in the last 24 months: Sciences Ltd. Roivant ($336,900,200.00).

Insiders have purchased a total of 16,845,010 IMVT shares in the last 24 months for a total of $336,900,200.00 bought.

The following insiders have sold IMVT shares in the last 24 months: Andrew J Fromkin ($674,089.25), Douglas J Hughes ($348,600.00), Eric Venker ($342,918.90), Eva Renee Barnett ($1,003,243.01), Jay S Stout ($806,669.23), Julia G Butchko ($139,121.17), Mark S Levine ($296,046.28), Melanie Gloria ($514,793.38), Michael Geffner ($326,761.50), Peter Salzmann ($2,930,794.05), Robert Graham Susman ($67,979.34), Tiago Girao ($763,011.20), Tuyl Christopher Van ($491,063.47), and William L Macias ($148,569.41).

Insiders have sold a total of 363,628 Immunovant shares in the last 24 months for a total of $8,853,660.19 sold.



This page (NASDAQ:IMVT) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners